The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
The Hippo Pathway Is Activated and Is a Causal Mechanism for Adipogenesis in Arrhythmogenic Cardiomyopathy
Open accessAbstract
RATIONALE: Mutations in the intercalated disc proteins, such as plakophilin 2 (PKP2), cause arrhythmogenic cardiomyopathy (AC). AC is characterized by the replacement of cardiac myocytes by fibro-adipocytes, cardiac dysfunction, arrhythmias, and sudden death. OBJECTIVE: To delineate the molecular pathogenesis of AC. METHODS AND RESULTS: Localization and levels of selected intercalated disc proteins, including signaling molecules, were markedly reduced in human hearts with AC. Altered protein constituents of intercalated discs were associated with activation of the upstream Hippo molecules in the human hearts, in Nkx2.5-Cre:Dsp(W/F) and Myh6:Jup mouse models of AC, and in the PKP2 knockdown HL-1 myocytes (HL-1(PKP2:shRNA)). Level of active protein kinase C-α isoform, which requires PKP2 for activity, was reduced. In contrast, neurofibromin 2 (or Merlin), a molecule upstream of the Hippo pathway and that is inactivated by protein kinase C-α isoform, was activated. Consequently, the downstream Hippo molecules mammalian STE20-like protein kinases 1/2 (MST1/2), large tumor suppressor kinases 1/2 (LATS1/2), and Yes-associated protein (YAP) (the latter is the effector of the pathway) were phosphorylated. Coimmunoprecipitation detected binding of phosphorylated YAP, phosphorylated β-catenin, and junction protein plakoglobin (the latter translocated from the junction). RNA sequencing, transcript quantitative polymerase chain reaction, and reporter assays showed suppressed activity of SV40 transcriptional enhancer factor domain (TEAD) and transcription factor 7-like 2 (TCF7L2), which are transcription factors of the Hippo and the canonical Wnt signaling, respectively. In contrast, adipogenesis was enhanced. Simultaneous knockdown of Lats1/2, molecules upstream to YAP, rescued inactivation of YAP and β-catenin and adipogenesis in the HL-1(PKP2:shRNA) myocytes. CONCLUSIONS: Molecular remodeling of the intercalated discs leads to pathogenic activation of the Hippo pathway, suppression of the canonical Wnt signaling, and enhanced adipogenesis in AC. The findings offer novel mechanisms for the pathogenesis of AC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a landmark study by Garcia-Gras E et al. [77], these authors demonstrated that suppression of canonical Wnt/β-catenin signaling leads to ACM, prominently through competition with nuclear localization of JUP, rather than through β-catenin degradation [77,79,80].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [79]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The loss of nuclear YAP in conjunction with Wnt/β-catenin suppression further drives adipogenesis and maladaptive fibrotic repair [79,80].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [79]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Conversely, in ACM, prior studies have demonstrated aberrant Hippo pathway activation and subsequent YAP inactivation [79].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [79]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Recent evidence implicates fibro-adipogenic progenitors and epicardial-derived cells as primary sources, and they typically show an epicardial to endocardial migration [77,79,83,84].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [79]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · Circulation · doi:10.1161/circulationaha.108.840827 · Cited by 2,676
Aragona, M., Panciera, T., Manfrin, A., Giulitti, S., Michielin, F., Elvassore, N., Dupont, S., & Piccolo, S. (2013) · Cell · doi:10.1016/j.cell.2013.07.042 · Cited by 1,651
Marcus, G. M., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H. G., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq025 · Cited by 1,610
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205
Phosphate-binding Tag, a New Tool to Visualize Phosphorylated Proteins
Kinoshita, E., Kinoshita‐Kikuta, E., Takiyama, K., & Koike, T. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t500024-mcp200 · Cited by 1,112
McKoy, G., Protonotarios, N., Crosby, A. H., Tsatsopoulou, A., Anastasakis, A., Coonar, A. S., Norman, M. W., BABOONIAN, C., Jeffery, S., & McKenna, W. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02379-5 · Cited by 1,101
Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size
Heallen, T. R., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L., & Martin, J. F. (2011) · Science · doi:10.1126/science.1199010 · Cited by 1,092
Corrado, D., Basso, C., Thiene, G., McKenna, W. J., Davies, M. J., Fontaliran, F., Nava, A., Silvestri, F., Blomstrom-Lundqvist, C., Wlodarska, E. K., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00332-x · Cited by 978
Arrhythmogenic right ventricular cardiomyopathy
Basso, C., Corrado, D., Marcus, G. M., Nava, A. K., & Thiene, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60256-7 · Cited by 938
Research works printed but not linked: 1
- 10.1128/MCB.13.9.5206 · DOI
Cited by
Sorted by citations
Items 201–275 of 275
Some Insights into the Regulation of Cardiac Physiology and Pathology by the Hippo Pathway
Ramaccini, D., Pedriali, G., Perrone, M., Bouhamida, E., Modesti, L., Wieckowski, M. R., Giorgi, C., Pinton, P., & Morciano, G. (2022) · Biomedicines · doi:10.3390/biomedicines10030726 · Cited by 9
Marinas, M. B., Celeghin, R., Cason, M., Thiene, G., Basso, C., & Pilichou, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176434 · Cited by 10
Niu, Y., Sun, Y., Liu, Y., Du, K., Xu, X., & Ding, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044106 · Cited by 8
Emerging Signaling Regulation of Sinoatrial Node Dysfunction
Zheng, M., Erhardt, S., Cao, Y., & Wang, J. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01885-8 · Cited by 7
Leucocyte-derived micro-RNAs as candidate biomarkers in Brugada syndrome
Steinberg, C., Gaudreault, N., Papadakis, A. I., Henry, C., Champagne, J., Philippon, F., O’Hara, G. E., Blier, L. E., Plourde, B., Nault, I., et al. (2023) · EP Europace · doi:10.1093/europace/euad145 · Cited by 7
Vencato, S., Romanato, C., Rampazzo, A., & Calore, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116208 · Cited by 7
Analysis of buccal mucosa as a prognostic tool in children with arrhythmogenic cardiomyopathy
Bueno‐Betí, C., Field, E., Tsatsopoulou, A., Perry, G., Sheppard, M. N., Behr, E. R., Saffitz, J. E., Kaski, J. P., & Asimaki, A. (2021) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2021.101458 · Cited by 7
Lippi, M., Maione, A. S., Chiesa, M., Perrucci, G. L., Iengo, L., Sattin, T., Cencioni, C., Savoia, M., Zeiher, A. M., Tundo, F., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210017 · Cited by 7
Gao, S., Chen, S. N., Nardo, C. D., & Lombardi, R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00834 · Cited by 8
Self-citationMicroRNAs: From Junk RNA to Life Regulators and Their Role in Cardiovascular Disease
Amodio, F., Caiazza, M., Fimiani, F., Calabrò, P., & Limongelli, G. (2021) · Cardiogenetics · doi:10.3390/cardiogenetics11040023 · Cited by 6
Ziemann, M., Wu, W., Deng, X., & Du, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.921610 · Cited by 6
Rosas, P. C., & Solaro, R. J. (2025) · Comprehensive physiology · doi:10.1002/cph4.70006 · Cited by 5
Exercise in Inherited Cardiomyopathies: Optimizing the Dose-Response Curve
Rye, E. E., Mitchell, A. M., Santiago, C. F., Gerche, A. L., & Fatkin, D. (2025) · Circulation Research · doi:10.1161/circresaha.125.326396 · Cited by 7
The Multifaceted Roles of Hippo-YAP in Cardiovascular Diseases
Wu, H., Che, Y., Lan, Q., He, Y.-X., Liu, P., Chen, M., Li, D., & Liu, M. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09926-6 · Cited by 5
Molecular and functional characterization of MST2 in grass carp during bacterial infection
Li, Y., Qiu, X., Lu, Z., Zhan, F., Yang, M., Babu, V. S., Li, J., Qin, Z., & Lin, L. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.09.026 · Cited by 5
Vallverdú-Prats, M., Carreras, D., Pérez, G. J., Campuzano, Ó., Brugada, R., & Alcalde, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032109 · Cited by 6
In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models
Risato, G., Casas, R. B., Cason, M., Marinas, M. B., Pinci, S., Gaspari, M. D., Visentin, S., Rizzo, S., Thiene, G., Basso, C., et al. (2024) · Cells · doi:10.3390/cells13151264 · Cited by 4
Wang, W., Cathcart, B., Nguyen, Q. D., Lao, L. Q., Bryans, A., Coleman, S. E., Rouhi, L., Gurha, P., & Marian, A. J. (2025) · JCI Insight · doi:10.1172/jci.insight.192283 · Cited by 4
Self-citationMolecular Pathogenesis of Arrhythmogenic Cardiomyopathy: Mechanisms and Therapeutic Perspectives
Popa, E., & Hostiuc, S. (2025) · Biomolecules · doi:10.3390/biom15111512 · Cited by 4
Desmosomes in Cell Fate Determination: From Cardiogenesis to Cardiomyopathy
Moazzen, H., Bolaji, M. D., & Leube, R. E. (2023) · Cells · doi:10.3390/cells12172122 · Cited by 4
Arrhythmogenic Cardiomyopathy: Mechanisms, Genetics, and Their Clinical Implications
Reuter, C. M., Dries, A. M., & Parikh, V. N. (2021) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-021-00669-5 · Cited by 4
Orgil, B., Spaulding, M. S., Smith, H. P., Baba, Z., Alberson, N. R., Batsaikhan, E., Towbin, J. A., & Purevjav, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146856 · Cited by 4
İnanç, İ., Bender, O., Atalay, A., & Erdemlı, E. (2025) · Scientific Reports · doi:10.1038/s41598-025-12819-5 · Cited by 3
Molecular Pathology of Cardiomyopathies: Bridging Morphology, Genomics, and Clinical Phenotypes
Marzullo, A., & Salzillo, C. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48010060 · Cited by 3
Yeh, Y.-H., Ko, Y.-S., Chan, Y.-H., Lai, Y.-J., Chang, G.-J., Chang, C.-J., & Hsu, L.-A. (2026) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.125.005434 · Cited by 3
Du, X., She, G., Wu, W., & Deng, X. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101941 · Cited by 3
Hippo pathway activation causes multiple lipid derangements in a murine model of cardiomyopathy
Wu, W., Huynh, K., Du, J.-C., She, G., Duong, T., Ziemann, M., Zhao, W., Deng, X., Meikle, P. J., & Du, X. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159590 · Cited by 3
Mostert, D., Ferron, S., Olmeda, C. V., Rampazzo, A., & Calore, M. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.08.012 · Cited by 3
Vencato, S., Romanato, C., Forino, M., Fossati, G., Velle, A., Facchinello, N., Braghetta, P., Licandro, S. A., Romualdi, C., Calore, M., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118549 · Cited by 3
The effect of plakophilin-2 gene mutations on the activity of canonical WNT signaling
Khudiakov, A. A., Kostina, D., Kostareva, A. A., Tomilin, A. N., & Malashicheva, A. (2016) · Cell and Tissue Biology · doi:10.1134/s1990519x16020061 · Cited by 3
Li, X., Huang, W., He, B., Zhou, L., Huang, X., & Yao, B. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5057 · Cited by 3
Role of miRNA–mRNA Interactome in Pathophysiology of Arrhythmogenic Cardiomyopathy
Bonet, F., Campuzano, Ó., Caballero, J., Alcalde, M., Sarquella‐Brugada, G., Braza‐Boïls, A., Brugada, R., Hernández‐Torres, F., Quezada-Feijoó, M., Ramos, M., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12081807 · Cited by 4
Bertoli, G., Phadke, K., Cospito, A., Rizk, J. A., Zhang, M., Miliotou, E., Cammer, M., Deng, Y., Mezzano, V., Alu, M., et al. (2025) · doi:10.1101/2025.10.22.682160 · Cited by 2
Genetic Animal Models of Cardiovascular Pathologies
Blagonravov, M. L., Ryabinina, A., Karpov, R. M., Ovechkina, V. S., Filatov, M. A., Silaeva, Y. Y., Syatkin, S. P., Agostinelli, E., Belousov, V. V., & Mozhaev, A. A. (2025) · Biomedicines · doi:10.3390/biomedicines13071518 · Cited by 3
Genomic and molecular evidence that the LncRNA DSP-AS1 modulates desmoplakin expression
Foco, L., Bortoli, M. D., Fabiola Del Greco, M., Frommelt, L. S., Volani, C., Riekschnitz, D. A., Motta, B. M., Fuchsberger, C., Delerue, T., Völker, U., et al. (2025) · Human Genetics · doi:10.1007/s00439-025-02761-x · Cited by 2
Maintenance of Energy Metabolism Is an Integral Part of Plakophilin-2 and Desmosome Functions
Aycinena, J. A., Tefera, A. E., Perea‐Gil, I., Holbrook‐Smith, D., Williams, K., Shenwai, R., Farshidfar, F., Ryback, B. M., Foppe, K. S., Wu, I., et al. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.101428 · Cited by 3
α-E-Catenin is a potential regulator of canonical Wnt and HIPPO-signallings in myocardium
Balatskyi, V. V., Palchevska, O., Macewicz, L. L., & Piven, O. O. (2016) · Visnik ukrains kogo tovaristva genetikiv i selekcioneriv · doi:10.7124/visnyk.utgis.14.2.682 · Cited by 2
Cerrone, M., Agulló-Pascual, E., & Delmar, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00022-5 · Cited by 3
Li, X., Yue, Y., Zhang, Y., Liao, Y., Wang, Q., Bian, Y., Na, J., & He, A. (2021) · Fundamental Research · doi:10.1016/j.fmre.2021.11.025 · Cited by 2
Circulation Research “In This Issue” Anthology
Williams, R. R. E., & Editors, T. (2017) · Circulation Research · doi:10.1161/res.0000000000000152 · Cited by 2
ARVC/D and the dyad: A long distance relationship?
Delmar, M. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.11.036 · Cited by 2
A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease
Ariyaratne, G. H. D. N., Villatore, A., Peretto, G., & Chelko, S. P. (2026) · Cells · doi:10.3390/cells15100868 · Cited by 2
Nikitina, E. V., Kofeynikova, O. А., Zlotina, A. M., Pervunina, T. M., Vasichkina, E. S., Головкин, А. С., Kalinina, O., & Kostareva, A. A. (2025) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v14.i4.108329 · Cited by 1
Desmoplakin Loss Leads to PKC- and Src-Mediated Contractile Dysfunction in Cardiomyocytes
Gokhan, I., McKay, M., Li, X., Zanetti, M., Granger, J. M., Sendek, J. M., Pagan, A. J. M., Campbell, K. S., Akar, F. G., & Campbell, S. G. (2026) · Circulation Research · doi:10.1161/circresaha.125.327676 · Cited by 1
PKP2 orchestrates OXPHOS expression in cardiomyocytes via a PGC1α-dependent mechanism
Han, S. J., van den Berg, D., de Ruiter, H., Tsui, H., Kyriakopoulou, E., Koopmans, T., Perini, I., Monshouwer‐Kloots, J., van Kampen, S. J., Riele, A. S. J. M. T., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag141 · Cited by 1
Pathogenesis, Diagnosis and Risk Stratification in Arrhythmogenic Cardiomyopathy
Florio, M. T., Boccia, F., Vetrano, E., Borrelli, M., Gossios, T. D., & Palmiero, G. (2021) · Cardiogenetics · doi:10.3390/cardiogenetics11040025 · Cited by 1
Alterations in the Hippo Signaling Pathway During Adenogenesis Impairment in Postnatal Mouse Uterus
İnanç, İ., Bender, O., Atalay, A., Köse, S. K., & Erdemlı, E. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01793-y · Cited by 1
Priori, S. G., & Mazzanti, A. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa049 · Cited by 1
Olcum, M., Fan, S., Rouhi, L., Cheedipudi, S. M., Cathcart, B., Jeong, H.-H., Zhao, Z., Gurha, P., & Marian, A. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.02.530831 · Cited by 1
Self-citationAycinena, J. A., Tefera, A. E., Perea‐Gil, I., Holbrook‐Smith, D., Williams, K. J., Shenwai, R., Farshidfar, F., Ryback, B. M., Foppe, K. S., Wu, I., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.17.633239 · Cited by 1
Gokhan, I., Li, X., Sendek, J. M., Pagan, A. J. M., Akar, F. G., & Campbell, S. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.15.654389 · Cited by 1
Further Evidence of Harm From Exercise in ARVD/C
Judge, D. P., & Chelko, S. P. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.046
Williams, R. (2014) · Circulation Research · doi:10.1161/circresaha.114.304939
Ventricular Tachycardias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Tandri, H. S., & Calkins, H. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00087-0
To Seek the Holy Grail of Cardiac Progenitor Cells
Marian, A. J. (2017) · Circulation Research · doi:10.1161/circresaha.117.312097
Self-citationRole of galectin-3 in the pathogenesis of arrhythmogenic cardiomyopathy—It’s complicated
Chelko, S. P., & Saffitz, J. E. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.04.022
Wnt/Frizzled signaling in myocardial infarction
Hermans, K. C. M. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160511kh
Ben‐Ze'ev, A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727611691.793550594
Circulation Research “In This Issue” Anthology
Williams, R. A., & Editors, T. (2015) · Circulation Research · doi:10.1161/res.0000000000000088
Molecular Pathways and Animal Models of Arrhythmias
Stevens, T. L., Coles, S. A., Sturm, A. C., Hoover, C. A., Borzok, M. A., Mohler, P. J., & Refaey, M. E. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-44087-8_67
Plakophilin-2 gene knockout using CRISPR/Cas9 system
Khudiakov, A. A., Kostina, D., Kostareva, A. A., & Malashicheva, A. (2016) · Genes and Cells · doi:10.23868/gc120597
Genetic Implications of Fatty Tissue for the Development of Ventricular Arrhythmias
Prisecaru, R. S., Purcar, O., & Maniţiu, I. (2025) · Cardiogenetics · doi:10.3390/cardiogenetics15010008
Rahman, M., Rahman, M. H., Hossain, M. A., Islam, K. M., Apu, P. S., Khan, M., Kibria, M. G., Ansari, S. A., & Humayoo, M. (2025) · Scientific Reports · doi:10.1038/s41598-024-78011-3 · Cited by 1
Fubylation as a Druggable Ubiquitin-Like Conjugation System Controlling Hippo Pathway ActivityPreprint
Bulos, M. L., Grzelak, E. M., Nutsch, K., Elshan, N. G. R. D., Chatterjee, A. K., & Bollong, M. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.06.663376
A zebrafish stable model of Galectin-3 to elucidate its role in Arrhythmogenic CardiomyopathyPreprint
Pilichou, K., Risato, G., Celeghin, R., Cason, M., Marinas, M. B., Pinci, S., Casas, R. B., Gaspari, M. D., Barbera, M. D., Facchinello, N., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7855683/v1
Pilichou, K., Basso, C., Corrado, D., & Thiene, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-702-08231-3.00062-4
Editorial commentary: The hot phases of arrhythmogenic cardiomyopathy: A burning issue
Bertoli, G., Cerrone, M., & Delmar, M. (2026) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2026.02.006
Blandin, C. (2023) · theses.fr (ABES) · doi:10.70675/bedafc9ez5195z4b52z913bz548743c18b89
Molecular mechanisms and RNA biomarkers in cardiomyopathy diagnosis
Kumar, S., Goyal, A., Wander, G. S., Duggal, B., Karnati, S., & Naidu, S. (2026) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen8336
Huang, C.-X., Kejia, J. I. N., Xiang, L.-Q., Lv, Z.-X., Wang, Y., Jia, J.-G., Wu, F.-Z., Zhu, Y.-Z., Zou, Y.-Z., Dai, Y.-X., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01846-1
Jia, L.-Y., Hai, X.-X., Wu, Z., Li, J.-J., Yang, Y., Hou, M., Wu, L., Han, M.-Z., Zhang, Y., Xu, Y., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09137-7
Liu, Z., Cui, H., Yang, T., Shu, S., Chen, Z., Han, J., Su, M., Huang, J., Chen, X., Song, J., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117251
Pasini, N., Barocelli, F., Bettella, A., Ristagno, A., Santoro, M., Canu, E., Crocamo, A., Gurgoglione, F. L., Triglia, L. T., Russo, F., et al. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm51364
Wattaladeniya, P. G., Mudiyanselage, V. P. M. M. G. W., & Snezhitskiy, V. А. (2026) · Кардиология в Беларуси · doi:10.34883/pi.2026.18.3.006
Metadata
- Authors
- Chen, S. N., Gurha, P., Lombardi, R., Ruggiero, A., Willerson, J. T., & Marian, A. J.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Venue
- Circulation Research
- Published
- 2014-01-31
- Volume
- 114
- Issue
- 3
- Pages
- 454-468
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC3946717
- OpenAlex
- W2170939446
- Cited by
- 275
- References
- 62
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 11 · 2023: 24 · 2022: 21 · 2021: 34 · 2020: 20 · 2019: 21 · 2018: 22 · 2017: 32 · 2016: 17 · 2015: 21 · 2014: 15
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R21AG038597)
- National Heart, Lung, and Blood Institute (R34HL105563, R01HL088498)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Keywords
- arrhythmogenic cardiomyopathy, Hippo signaling pathway, adipogenesis, plakophilin-2, intercalated discs, protein kinase C alpha, Merlin, YAP, MST1/2, LATS1/2, Wnt/β-catenin signaling, β-catenin, plakoglobin
- MeSH terms
- Hippo Signaling Pathway, Animals, Cell Line, Humans, Signal Transduction, Protein Serine-Threonine Kinases, Mice, Knockout, Arrhythmogenic Right Ventricular Dysplasia, Adipogenesis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
